Shannon Donegan, PA
Physician Assistant · Castle Rock
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 7
Offices
7 locations · Portercare Adventist Health System · 770 clinicians in this group
Looking this up.
Hospitals listed: Adventhealth Littleton. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Shannon Donegan’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Colorado PA.7622Physician assistant · since 2022 · expires 2028-01-31ActiveNo board action on this licenceCheck it with the stateWhat they told the state about themselves
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventhealth LittletonLittleton, COAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of AdventHealth, which runs 42 hospitals in 9 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.292, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventhealth Littleton
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.292 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.13 to 2.14) · 659 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.72 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.64 (115.59 to 217.69) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.9 · 53 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 293 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 308 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 2,575 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.01 to 0.43) · 4,124 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,030 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.6 (1.48 to 5.73) · 1,035 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.89 (0.26 to 3.51) · 360 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.25 (1.68 to 4.81) · 973 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.62 (5.96 to 21.28) · 371 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.77 (0.96 to 8.58) · 350 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.15) · 193 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0 to 1.34) · 3,176 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 49 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.617 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.01 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.425 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 143 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 474 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 9.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14.3 · 329 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.6 · 323 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 477 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 50 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 99 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.6 to 16.8) · 406 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 340 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,114 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$5,152
Medicare paid this office $5,152 for 45 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 27 | $2,425 | $58 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
45 Original Medicare patients in 2024. Average age 72 · Women 100% · Health risk score 1.06. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 67% · Depression 29%.
The office billed $24,401, Medicare allowed $6,638 and paid $5,152; for 103 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 45 | 103 | 72 | 1.06 | $24,401 | $5,152 |
| 2023 | 175 | 279 | 77 | 0.96 | $94,954 | $17,456 |
| 2022 | 395 | 975 | 77 | 0.86 | $335,935 | $78,349 |
| 2021 | 295 | 802 | 78 | 0.89 | $247,952 | $60,898 |
| 2020 | 276 | 756 | 77 | 1.00 | $214,741 | $49,620 |
| 2019 | 200 | 706 | 76 | 0.96 | $184,232 | $43,666 |
| 2018 | 84 | 329 | 74 | 1.02 | $80,346 | $18,971 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 104 | $5,842 | $50 |
| Return visit (30+ min) | 28 | $2,290 | $82 |
| Surgical repair of vaginal defect using an endoscope | 15 | $1,533 | $102 |
| Creation of sling around urethra in female to control leakage | 15 | $757 | $50 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 12 | $553 | $46 |
2022: 16 services
| Short return visit (20+ min) | 219 | $24,692 | $72 |
| Return visit (30+ min) | 137 | $14,393 | $97 |
| Insertion of lower leg neurostimulator electrode | 43 | $7,282 | $110 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 16 | $5,755 | $360 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 13 | $4,137 | $318 |
| Insertion of device into abdomen with pressure and urine flow rate study | 14 | $2,605 | $186 |
| Surgical repair of vaginal defect using an endoscope | 21 | $2,514 | $120 |
| Pessary, reusable, non rubber, any type | 42 | $2,030 | $44 |
| Fitting and insertion of vaginal support device | 33 | $1,816 | $55 |
| Insertion of temporary bladder tube | 36 | $1,496 | $36 |
| Creation of sling around urethra in female to control leakage | 26 | $1,283 | $49 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 30 | $850 | $27 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 15 | $788 | $53 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 11 | $786 | $71 |
| Repair of herniated rectum into vaginal wall | 15 | $630 | $42 |
| Electronic assessment of bladder emptying | 28 | $167 | $6 |
2021: 11 services
| Short return visit (20+ min) | 150 | $13,057 | $62 |
| Return visit (30+ min) | 112 | $12,821 | $96 |
| Insertion of lower leg neurostimulator electrode | 50 | $10,287 | $108 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $1,917 | $174 |
| Insertion of temporary bladder tube | 35 | $1,489 | $36 |
| Surgical repair of vaginal defect using an endoscope | 12 | $1,469 | $122 |
| Pessary, reusable, non rubber, any type | 24 | $1,238 | $44 |
| Fitting and insertion of vaginal support device | 16 | $1,090 | $61 |
| Creation of sling around urethra in female to control leakage | 15 | $711 | $47 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 13 | $368 | $28 |
| Electronic assessment of bladder emptying | 12 | $70 | $6 |
2020: 9 services
| Short return visit (20+ min) | 143 | $12,681 | $56 |
| Insertion of lower leg neurostimulator electrode | 41 | $8,788 | $110 |
| Return visit (30+ min) | 78 | $7,528 | $86 |
| Insertion of temporary bladder tube | 75 | $3,328 | $34 |
| Pessary, reusable, non rubber, any type | 24 | $1,430 | $43 |
| Short return visit | 29 | $1,114 | $37 |
| Creation of sling around urethra in female to control leakage | 13 | $844 | $65 |
| Fitting and insertion of vaginal support device | 14 | $707 | $47 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $678 | $62 |
2019: 12 services
| Insertion of lower leg neurostimulator electrode | 38 | $12,021 | $96 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 46 | $9,209 | $196 |
| Short return visit (20+ min) | 85 | $6,922 | $51 |
| Insertion of device into abdomen with pressure and urine flow rate study | 44 | $3,656 | $81 |
| Return visit (30+ min) | 41 | $3,550 | $79 |
| Insertion of temporary bladder tube | 36 | $1,754 | $37 |
| Pessary, reusable, non rubber, any type | 24 | $1,332 | $43 |
| Short return visit | 22 | $1,259 | $30 |
| Fitting and insertion of vaginal support device | 24 | $1,147 | $40 |
| Automated urinalysis test | 52 | $159 | $2 |
| Ultrasound measurement of bladder capacity after voiding | 12 | $128 | $11 |
| Electronic assessment of bladder emptying | 44 | $116 | $3 |
2018: 9 services
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 23 | $4,494 | $195 |
| Short return visit (20+ min) | 37 | $3,570 | $50 |
| Insertion of device into abdomen with pressure and urine flow rate study | 23 | $1,517 | $66 |
| Fitting and insertion of vaginal support device | 13 | $950 | $53 |
| Pessary, reusable, non rubber, any type | 16 | $921 | $44 |
| Short return visit | 22 | $919 | $30 |
| Return visit (30+ min) | 12 | $896 | $75 |
| Automated urinalysis test | 23 | $84 | $3 |
| Electronic assessment of bladder emptying | 21 | $77 | $4 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 18 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Subsequent prenatal care visit (Prenatal) [Excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg, an upper respiratory infection; patients seen for consultation only, not for continuing care)] | 18 | $0 |
| 2024 | 18 | 1 | 13 | $0 |
Drugs they prescribed that Part D paid
$37,471
Pharmacies billed $37,471 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 128) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
77 generic and 51 brand-name prescriptions · $37,471 in drug cost · 15 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 14 | $15,368 | $1,098 |
| Premarin | 19 | $8,116 | $427 |
| Estradiol | 38 | $2,704 | $71 |
Year by year
| 2024 | 128 | 68 | 0% (0) | 40% | $37,471 |
| 2023 | 523 | 223 | 5% (26) | 44% | $184,889 |
| 2022 | 876 | 364 | 6% (56) | None | $236,980 |
| 2021 | 780 | 315 | 7% (55) | None | $177,711 |
| 2020 | 815 | 328 | 5% (39) | 33% | $128,672 |
| 2019 | 223 | 106 | None | 55% | $47,572 |
| 2018 | 54 | 35 | None | 56% | $11,941 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Myrbetriq | 81 | $79,058 | $976 |
| Gemtesa | 31 | $40,683 | $1,312 |
| Premarin | 61 | $27,035 | $443 |
| Estring | 37 | $20,611 | $557 |
| Estradiol | 62 | $6,023 | $97 |
| Methenamine Hippurate | 33 | $4,983 | $151 |
| Nitrofurantoin Mono-Macro | 31 | $546 | $18 |
| Cephalexin | 44 | $289 | $7 |
| Metronidazole | 17 | $269 | $16 |
| Ibuprofen | 21 | $162 | $8 |
| Oxycodone | 18 | $72 | $4 |
| Fluconazole | 13 | $63 | $5 |
2022: 16 drugs
| Myrbetriq | 136 | $120,802 | $888 |
| Gemtesa | 48 | $42,453 | $884 |
| Premarin | 67 | $29,177 | $435 |
| Estring | 38 | $19,929 | $524 |
| Methenamine Hippurate | 60 | $8,022 | $134 |
| Estradiol | 78 | $7,923 | $102 |
| Nitrofurantoin | 19 | $1,365 | $72 |
| Nitrofurantoin Mono-Macro | 78 | $1,121 | $14 |
| Metronidazole | 29 | $601 | $21 |
| Cephalexin | 57 | $450 | $8 |
| Ibuprofen | 52 | $358 | $7 |
| Oxycodone | 50 | $263 | $5 |
| Clobetasol Propionate | 13 | $191 | $15 |
| Fluconazole | 23 | $158 | $7 |
| Sulfamethoxazole-Trimethoprim | 29 | $85 | $3 |
| Ciprofloxacin | 15 | $77 | $5 |
2021: 15 drugs
| Myrbetriq | 132 | $101,323 | $768 |
| Premarin | 63 | $25,953 | $412 |
| Estring | 37 | $18,567 | $502 |
| Estradiol | 81 | $12,471 | $154 |
| Methenamine Hippurate | 37 | $4,551 | $123 |
| Nitrofurantoin Mono-Macro | 82 | $1,154 | $14 |
| Oxybutynin Chloride Er | 15 | $823 | $55 |
| Cephalexin | 48 | $409 | $9 |
| Ibuprofen | 48 | $279 | $6 |
| Oxycodone | 42 | $230 | $5 |
| Metronidazole | 18 | $157 | $9 |
| Sulfamethoxazole-Trimethoprim | 40 | $116 | $3 |
| Hydrocodone-Acetaminophen | 12 | $73 | $6 |
| Ciprofloxacin | 17 | $53 | $3 |
| Fluconazole | 14 | $50 | $4 |
2020: 16 drugs
| Myrbetriq | 58 | $46,163 | $796 |
| Premarin | 78 | $30,732 | $394 |
| Estring | 26 | $12,362 | $475 |
| Estradiol | 56 | $10,817 | $193 |
| Estrace | 26 | $9,954 | $383 |
| Toviaz | 14 | $4,994 | $357 |
| Methenamine Hippurate | 37 | $4,104 | $111 |
| Nitrofurantoin Mono-Macro | 150 | $1,854 | $12 |
| Oxybutynin Chloride Er | 16 | $671 | $42 |
| Metronidazole | 45 | $655 | $15 |
| Cephalexin | 56 | $315 | $6 |
| Ibuprofen | 33 | $284 | $9 |
| Oxycodone | 33 | $182 | $6 |
| Ciprofloxacin | 29 | $138 | $5 |
| Fluconazole | 27 | $119 | $4 |
| Sulfamethoxazole-Trimethoprim | 50 | $104 | $2 |
2019: 8 drugs
| Estring | 47 | $20,366 | $433 |
| Myrbetriq | 19 | $12,117 | $638 |
| Premarin | 27 | $10,138 | $375 |
| Estradiol | 11 | $1,762 | $160 |
| Methenamine Hippurate | 16 | $909 | $57 |
| Metronidazole | 15 | $245 | $16 |
| Nitrofurantoin Mono-Macro | 21 | $224 | $11 |
| Cephalexin | 21 | $124 | $6 |
2018: 1 drug
| Premarin | 13 | $4,504 | $346 |
Money from drug and device companies
$627 in 2024
| 2024 | 2 | 12 | None | $627 |
| 2023 | 3 | 5 | None | $280 |
| 2022 | 1 | 1 | None | $174 |
| 2021 | 1 | 1 | None | $62 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Interstim | $604 | 11 payments
|
| Abbvie | Lupron Depot | $23 | 1 payment
|
See all 12 published payments
| Abbvie | Meals · 2024-05-21 | Lupron Depot | $23 |
| Medtronic | Travel · 2024-02-04 | Interstim | $50 |
| Medtronic | Travel · 2024-02-04 | Interstim | $51 |
| Medtronic | Meals · 2024-02-03 | Interstim | $13 |
| Medtronic | Meals · 2024-02-03 | Interstim | $7 |
| Medtronic | Meals · 2024-02-03 | Interstim | $62 |
| Medtronic | Meals · 2024-02-03 | Interstim | $45 |
| Medtronic | Meals · 2024-02-02 | Interstim | $126 |
| Medtronic | Travel · 2024-02-02 | Interstim | $199 |
| Medtronic | Travel · 2024-02-02 | Interstim | $34 |
| Medtronic | Meals · 2024-01-31 | Interstim | $10 |
| Medtronic | Meals · 2024-01-25 | Interstim | $8 |
See earlier years (2023, 2022, 2021)
2023: $280
| Medtronic | Interstim | $231 | 2 payments
|
| Abbvie | Liletta | $34 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Mirena | $14 | 1 payment
|
2022: $174
| Medtronic | Interstim | $174 | 1 payment
|
2021: $62
| Coloplast | Restorelle | $62 | 1 payment
|
Professional record
- NPI
- 1497264246
- Licence
- CA PA57225, CO PA.0007622Colorado PA.7622: Active
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- OR 500733841, WA 2088082
- Taxonomy
- Physician assistant, surgical (363AS0400X); Physician assistant, medical (363AM0700X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-09-25
- NPI last updated
- 2023-03-10
- NPI record certified
- 2023-03-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 7720 S Broadway Ste 250, Littleton, CO, 80122